Anti-CRIP1 monoclonal antibody
Pre-made anti-CRIP1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to CRIP1/CRIP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2437-Ab-1/ GM-Tg-hg-IP2437-Ab-2 | Anti-Human CRIP1 monoclonal antibody | Human |
GM-Tg-rg-IP2437-Ab-1/ GM-Tg-rg-IP2437-Ab-2 | Anti-Rat CRIP1 monoclonal antibody | Rat |
GM-Tg-mg-IP2437-Ab-1/ GM-Tg-mg-IP2437-Ab-2 | Anti-Mouse CRIP1 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2437-Ab-1/ GM-Tg-cynog-IP2437-Ab-2 | Anti-Cynomolgus/ Rhesus macaque CRIP1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2437-Ab-1/ GM-Tg-felg-IP2437-Ab-2 | Anti-Feline CRIP1 monoclonal antibody | Feline |
GM-Tg-cang-IP2437-Ab-1/ GM-Tg-cang-IP2437-Ab-2 | Anti-Canine CRIP1 monoclonal antibody | Canine |
GM-Tg-bovg-IP2437-Ab-1/ GM-Tg-bovg-IP2437-Ab-2 | Anti-Bovine CRIP1 monoclonal antibody | Bovine |
GM-Tg-equg-IP2437-Ab-1/ GM-Tg-equg-IP2437-Ab-2 | Anti-Equine CRIP1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2437-Ab-1/ GM-Tg-hg-IP2437-Ab-2; GM-Tg-rg-IP2437-Ab-1/ GM-Tg-rg-IP2437-Ab-2; GM-Tg-mg-IP2437-Ab-1/ GM-Tg-mg-IP2437-Ab-2; GM-Tg-cynog-IP2437-Ab-1/ GM-Tg-cynog-IP2437-Ab-2; GM-Tg-felg-IP2437-Ab-1/ GM-Tg-felg-IP2437-Ab-2; GM-Tg-cang-IP2437-Ab-1/ GM-Tg-cang-IP2437-Ab-2; GM-Tg-bovg-IP2437-Ab-1/ GM-Tg-bovg-IP2437-Ab-2; GM-Tg-equg-IP2437-Ab-1/ GM-Tg-equg-IP2437-Ab-2 |
Products Name | Anti-CRIP1 monoclonal antibody |
Format | mab |
Target Name | CRIP1 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-CRIP1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2437-Ag-1 | Recombinant multi-species CRIP1/ CRHP/ CRIP protein |
ORF Viral Vector | vGMLP000219 | human CRIP1 Lentivirus particle |
ORF Viral Vector | pGMLP000219 | human CRIP1 Lentivirus plasmid |
ORF Viral Vector | pGMLPm000065 | mouse Crip1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm000065 | mouse Crip1 Lentivirus particle |
Target information
Target ID | GM-IP2437 |
Target Name | CRIP1 |
Gene ID | 1396,12925,691657,699632,612713,101101478,574093,100630592 |
Gene Symbol and Synonyms | CRHP,CRIP,CRIP1,CRP-1,CRP1 |
Uniprot Accession | P50238,P63255,Q56K04 |
Uniprot Entry Name | CRIP1_HUMAN,CRIP1_RAT,CRIP1_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | Ovary Cancer |
Gene Ensembl | ENSG00000213145 |
Target Classification | N/A |
The target: CRIP1, gene name: CRIP1, also named as CRHP, CRIP, CRP-1, CRP1. Cysteine-rich intestinal protein (CRIP) belongs to the LIM/double zinc finger protein family, members of which include cysteine- and glycine-rich protein-1 (CSRP1; MIM 123876), rhombotin-1 (RBTN1; MIM 186921), rhombotin-2 (RBTN2; MIM 180385), and rhombotin-3 (RBTN3; MIM 180386). CRIP may be involved in intestinal zinc transport (Hempe and Cousins, 1991 [PubMed 1946385]).[supplied by OMIM, Mar 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.